NCT03377881Active, not recruiting
Prostate Cancer Detection Using the Stockholm3 Test and MR/Fusion Biopsies
STHLM3 MR Phase 2: A New Diagnostic Chain for Prostate Cancer Detection Using the Stockholm3 Test and MR/Fusion Biopsies
Source: ClinicalTrials.gov · Last updated 26 Dec 2023
Brief summary (registry, in English)
The STHLM3-MRI trial is a study comparing traditional prostate cancer detection using PSA and systematic biopsies with the improved pipeline for prostate cancer detection using the STHLM3 test and targeted biopsies in a screening context. The study includes individualised repeat invitations for re-screening to participants not diagnosed with prostate cancer.
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 12750 (actual)
- First submitted
- 28 Nov 2017
- Start date
- 4 Apr 2018
- Primary completion date
- 10 Dec 2020
- Lead sponsor
- Karolinska Institutet
- Diseases
- Prostate cancer
- NCT number
- NCT03377881
What you commit to
- Study type: Interventional
- Participants enrolled: 12750
- From 4 Apr 2018 to the primary completion date, 10 Dec 2020
- 3 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- • Severe illnesses such as metastatic cancers, severe cardio-vascular disease or dementia
- Contraindications for magnetic resonance imaging (MRI) eg pacemaker, magnetic cerebral clips, cochlear implants or severe claustrophobia.
Who the study is looking for
- Permanent postal address in Stockholm
Age in the registry: 50 years to 74 years · Sex: Male · Accepts healthy volunteers
Sites (3)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| C-medical Odenplan Urology Coordinator of this site? Confirm its status | Stockholm | Sweden | Unknown status |
| Capio St.Görans Hospital Coordinator of this site? Confirm its status | Stockholm | Sweden | Unknown status |
| Urologifocus Coordinator of this site? Confirm its status | Stockholm | Sweden | Unknown status |
Related publications
- Stockholm3-Magnetic Resonance Imaging Population-Based Prostate Cancer Screening Study: Two-Year Follow-up.Ann Intern Med · 2026 · PMID 42330502
This page is information, not medical advice. Discuss any trial with your doctor.